Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superior Hypogastric Nerve Block for Pain Control After Uterine Artery Embolization
NCT04126824Phase 1Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2022
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of triamcinolone in postoperative pain (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Change in Pain Intensity Measure at 240 hours. Started Jan 2022; status: active, not recruiting.
02
Drugs
triamcinolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04126824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04126824.